On March 9, 2017 the price of NVDQ stock closed at $7.21@
On March 20, 2017 NVDQ announced the completion of the FILM enrollment. Stock price $7.81@
The next on the list was for a second of the big three remaining insurance companies (~51% of total US coverage) to announce acceptance of DermACELL--ETA mid-April. This should be good for ~$0.50 per share bump.
I noticed the Shorts have increased their positions by about 500k shares recently. Are they right or are they setting themselves up for a slow bleed?
GSA